ARPneuro is the largest US distributor of the FDA-cleared, Class II neuromuscular electric stimulation device (RX100) that Healthcare Professionals use in their office to provide ARPneuro Therapy for patients suffering from painful conditions and muscular disuse atrophy. Using the RX100, patented therapy protocols are followed to diagnose the origin of pain, which is often located in a different location than where the symptom of pain is felt. Active movement during ARPneuro Therapy neurologically re-educates the muscles to allow for proper movement. Blood flow is increased through muscle contractions at a rate of 500 times per second, which promotes healing and speeds up recovery. ARPneuro Therapy protocols cover a wide range of painful conditions including low back pain; tennis elbow; concussion; frozen shoulder; and plantar fasciitis. These are only a few examples of ARPneuro Therapy protocols. Patients suffering from Neuropathy also experience relief with ARPneuro Therapy. Patients who are pregnant, have an implanted electrical device, or a history of blood clots are not candidates for ARPneuro Therapy. Cancer is not a contraindication, however, patients should consult with their specialist prior to starting ARPneuro Therapy. ARPneuro provides complimentary in-office product demos. To learn more, please visit www.arpneuro.com. ARPneuro also distributes the ARPneuro at Home device (PRS) that contracts the muscles at a rate of 245 times per second. ARPneuro at Home can be utilized for maintenance in between in-office treatments with the RX100; increased blood flow; improved performance; and strengthening.